Researchers at Calviri have discovered a new biomarker in lung cancer patients that could better predict treatment response.
Tag: Stephen Johnston
PBC Company Calviri announces enrollment of 800 dogs in preventative cancer vaccine trial
Vaccine Against Canine Cancer Study (VACCS), with 800 dogs, making it the largest interventional canine clinical trial in the history of veterinary medicine.
Calviri CEO Dr. Stephen Johnston on cancer eradication
Phoenix Bioscience Core-based Calviri Inc.’s founder Dr. Stephen Johnston recently spoke to Progress, Potential and Possibilities on eradicating cancer via a universival preventative cancer vaccine.